36C26024F0071↗
Alexion Pharmaceuticals Inc received this contract from 260-Network Contract Office 20 (36C260), Department of Veterans Affairs: $187.9K obligated so far for drugs and biologicals. Its period of performance ended 2024-01-31.
Key facts · data as of Oct 23, 2026
- Recipient
- Alexion Pharmaceuticals Inc
- Awarding agency
- Department of Veterans Affairs
- Contracting office
- 260-Network Contract Office 20 (36C260) (36C260)
- Obligated to date
- $187.9K
- Potential value
- $187.9K
- Ends
- 2024-01-31
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 23, 2026.
Cite this page: SpendQuery, Award 36C26024F0071, data as of Oct 23, 2026, https://spendquery.com/award?id=CONT_AWD_36C26024F0071_3600_36F79718D0355_3600
Alexion Pharmaceuticals Inc: all federal awards · Department of Veterans Affairs: spending · 260-Network Contract Office 20 (36C260): what it buys
STRENSIQ
What it is
- Product or service
- Drugs and Biologicals (PSC 6505)
- Industry
- Pharmaceutical Preparation Manufacturing (NAICS 325412)
- Contracting office
- 260-Network Contract Office 20 (36C260) (36C260)
- Competition
- Full and open competition · 1 offer received
- Pricing
- Firm fixed price
- How it was bought
- GSA Schedule · under 36F79718D0355
- Where the work is
- Suffolk, MA · district MA-08
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
1 action since 2023-11-03. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2023-11-03 | 0 | $187.9K | STRENSIQ |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-23). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗